These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31090512)

  • 1. The Potential of CRISPR/Cas9 in Hematotherapy.
    Bak RO
    Stem Cells Dev; 2019 Jun; 28(11):710-711. PubMed ID: 31090512
    [No Abstract]   [Full Text] [Related]  

  • 2. Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy.
    Li C; Mei H; Hu Y
    Brief Funct Genomics; 2020 May; 19(3):175-182. PubMed ID: 31950135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEGA-CRISPR tool gives a power boost to cancer-fighting cells.
    Reardon S
    Nature; 2024 Feb; 626(8001):940. PubMed ID: 38383653
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematotherapy.
    Mussolino C
    Stem Cells Dev; 2019 Jun; 28(11):714. PubMed ID: 31081744
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy.
    Liu X; Zhao Y
    Curr Res Transl Med; 2018 May; 66(2):39-42. PubMed ID: 29691200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
    Mollanoori H; Shahraki H; Rahmati Y; Teimourian S
    Hum Immunol; 2018 Dec; 79(12):876-882. PubMed ID: 30261221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy.
    Wellhausen N; Agarwal S; Rommel PC; Gill SI; June CH
    Curr Opin Immunol; 2022 Feb; 74():76-84. PubMed ID: 34798542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 genome editing for cancer immunotherapy: opportunities and challenges.
    Chen M; Xu J; Zhou Y; Zhang S; Zhu D
    Brief Funct Genomics; 2020 May; 19(3):183-190. PubMed ID: 31788683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges.
    Zhi L; Su X; Yin M; Zhang Z; Lu H; Niu Z; Guo C; Zhu W; Zhang X
    Cell Immunol; 2021 Nov; 369():104436. PubMed ID: 34500148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 12. The CRISPR-Cas9 Genome Editing System: Not as Precise as Previously Believed.
    Mattei TA
    World Neurosurg; 2018 Oct; 118():377-378. PubMed ID: 30114543
    [No Abstract]   [Full Text] [Related]  

  • 13. The CRISPR/Cas9 Genome Editing Revolution.
    Jiao R; Gao C
    J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
    [No Abstract]   [Full Text] [Related]  

  • 14. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
    Hohmann S
    Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
    [No Abstract]   [Full Text] [Related]  

  • 15. Super-precise CRISPR tool enters US clinical trials for the first time.
    Ledford H
    Nature; 2023 Sep; 621(7980):667-668. PubMed ID: 37723277
    [No Abstract]   [Full Text] [Related]  

  • 16. Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
    Wälchli S; Sioud M
    Methods Mol Biol; 2020; 2115():407-417. PubMed ID: 32006413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
    Tang L; Gong M; Zhang P
    Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Transcript CRISPR-Cas9 System for Efficient Genome Editing in Plants.
    Tang X; Zheng X; Qi Y; Zhang D; Cheng Y; Tang A; Voytas DF; Zhang Y
    Mol Plant; 2016 Jul; 9(7):1088-91. PubMed ID: 27212389
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.